Aeterna Zentaris to Present at Upcoming Rodman & Renshaw Annual Global Investment Conference in New York

About this update from Cosciens Biopharma Inc.

[{"type":"text","content":"\n\nQUÉBEC CITY, Sept. 3, 2015 /CNW Telbec/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the \"Company\") today announced that the Company's Chief Financial Officer, Dennis Turpin, will be presenting a corporate overview at the Rodman & Renshaw 17th Annual Global Investment Conference on Wednesday, September 9, 2015, at 10:25 am (Eastern), in the Library Room (2nd floor) of the St. Regis Hotel in New York City.\n\nAbout Aeterna Zentaris Inc.\n\nAeterna Zentaris is a specialty biopharmaceutical company engaged in developing and commercializing novel treatments in oncology, endocrinology and women's health. For more information, visit www.aezsinc.com.\n\n \nSOURCE Aeterna Zentaris Inc.\n\n\n\nPaul Burroughs, Director of Communications, (418) 652-8525 ext. 406, [email protected] CNW Group 2015","length":1442,"tagName":"div"}]

More updates from Cosciens Biopharma Inc.